NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kerna Laboratories

Kerna Laboratories

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://kernalabs.ai/

Last Round

Seed

Jan 13, 2025

Total Funding Raised

$6M

Company Overview

Kerna Laboratories Inc. is an AI biotechnology company that develops a platform for creating novel RNA-based medicines.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Foundation

Keywords

mRNA therapeuticsAI drug discoveryfoundation modelsmRNA designgenetic medicinesgenerative biologyprogrammable medicinesAI biotechnologybiotech AIin silico drug discoverymRNA optimizationdrug discovery platformcell-type specific targetingprotein expressionmRNA stability

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kerna Laboratories Comparables

Compare Kerna Laboratories with similar companies based on industry and business-model similarity.

Kerna Laboratories comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Kerna Laboratories Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 13, 2025

Kerna Laboratories Investors

Notable investors and investment history

Kerna Laboratories investors
InvestorRounds
Gradient VenturesSeed
Pioneer FundSeed
StoryHouseSeed
Tau VenturesSeed
Humba VenturesSeed
FocalPoint PartnersSeed
XEIA Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 51% MoM, from 1.3K to 2K.

  • Jul 23, 2025

    Grew 60% QoQ from 5 to 8 employees.

Kerna Laboratories Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kerna Laboratories Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kerna Laboratories's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.